Author

Alajos Pár 1

1 University of Pecs,Pecs,Hungary

DIRECT ACTING ANTIVIRAL TREATMENT DECREASES INHIBITORY TIM-3 IMMUNE CHECKPOINT RECEPTOR EXPRESSION ON NK CELLS IN PATIENTS WITH CHRONIC HCV HEPATITIS

Gabriella Par, Laszlo Szereday, Matyas Meggyes, Timea Berki, Attila Miseta, Nelli Farkas, Alajos Pár

DOES NORMAL ALT MEAN HEALTHY LIVER IN HCV INFECTION ?

Gabriella Par, Helga Hajdu, Aron Vincze, Attila Miseta, Alajos Pár

GUT BARRIER FAILURE BIOMARKERS ARE ASSOCIATED WITH POOR DISEASE OUTCOME IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS

Tornai Tamás, György Kovács, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Gabor Laszlo Veres, Zakera Shums, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas, Mária Papp

INCREASED BASELINE PROINFLAMMATORY CYTOKINE PRODUCTION IN CHRONIC HEPATITIS C PATIENTS WITH RAPID VIROLOGICAL RESPONSE TO PEGINTERFERON PLUS RIBAVIRIN

Gabriella Par, Laszlo Szereday, Timea Berki, Laszlo Palinkas, Aron Vincze, Alajos Pár

LIVER STIFFNESS MEASUREMENT PREDICTS THE PRESENCE OF LARGE OESOPHAGEAL VARICES IN PATIENTS WITH CHRONIC LIVER DISEASES

Gabriella Par, Andrea Trosits, Ferenc Pakodi, Peter Kenyeres, Aron Vincze, Alajos Pár

TARGET-SPECIFIC ANTI-PANCREATIC ANTIBODIES ARE FREQUENT IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND ASSOCIATED WITH POOR DISEASE OUTCOME

Mária Papp, Tornai Tamás, Nora Sipeki, Zsuzsanna Vitális, István Tornai, Kai Fechner, Dirk Roggenbuck, David Tornai, Gary L. Norman, Zakera Shums, Gabor Laszlo Veres, Péter Orosz, Béla Lombay, Judit Gervain, Gabriella Par, Alajos Pár, Peter L Lakatos, Ferenc Szalay, Peter Antal-Szalmas

Item 1 - 6 / 12
1
2